Andrew Saunders
Hoofd Techniek/Wetenschap/O&O bij CellCentric Ltd.
Profiel
Andrew Saunders is currently the Chief Medical Officer at CellCentric Ltd.
He previously worked as the Managing Director at Linden Oncology Ltd.
and as the Chief Medical Officer at Bioenvision, Inc. and Lytix Biopharma AS.
He also served as the Co-Chief Medical Officer at Redx Pharma Plc from 2018 to 2021.
Dr. Saunders earned a doctorate degree from Trinity College Dublin in 1989.
Actieve functies van Andrew Saunders
Bedrijven | Functie | Begin |
---|---|---|
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Andrew Saunders
Bedrijven | Functie | Einde |
---|---|---|
REDX PHARMA PLC | Hoofd Techniek/Wetenschap/O&O | 01-03-2021 |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Hoofd Techniek/Wetenschap/O&O | 09-04-2007 |
Linden Oncology Ltd. | Algemeen Directeur | - |
LYTIX BIOPHARMA | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Andrew Saunders
Trinity College Dublin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
LYTIX BIOPHARMA | Health Technology |
REDX PHARMA PLC | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Health Services |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Linden Oncology Ltd. |